GR3033985T3 - Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists. - Google Patents

Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists.

Info

Publication number
GR3033985T3
GR3033985T3 GR20000401670T GR20000401670T GR3033985T3 GR 3033985 T3 GR3033985 T3 GR 3033985T3 GR 20000401670 T GR20000401670 T GR 20000401670T GR 20000401670 T GR20000401670 T GR 20000401670T GR 3033985 T3 GR3033985 T3 GR 3033985T3
Authority
GR
Greece
Prior art keywords
fusedheterocyclic
diaryl
acids
leukotriene antagonists
compounds
Prior art date
Application number
GR20000401670T
Other languages
English (en)
Inventor
Robert N Young
Yi Bin Xiang
Marc Labelle
Cheuk K Lau
Yves Leblanc
Claude Dufresne
Yves Gareau
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of GR3033985T3 publication Critical patent/GR3033985T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
GR20000401670T 1992-12-22 2000-07-19 Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists. GR3033985T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99486992A 1992-12-22 1992-12-22

Publications (1)

Publication Number Publication Date
GR3033985T3 true GR3033985T3 (en) 2000-11-30

Family

ID=25541163

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401670T GR3033985T3 (en) 1992-12-22 2000-07-19 Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists.

Country Status (23)

Country Link
EP (1) EP0604114B1 (el)
KR (1) KR100310552B1 (el)
CN (1) CN1040213C (el)
AT (1) ATE192448T1 (el)
AU (1) AU672837B2 (el)
CA (1) CA2111372C (el)
CZ (1) CZ290829B6 (el)
DE (1) DE69328540T2 (el)
DK (1) DK0604114T3 (el)
ES (1) ES2145765T3 (el)
FI (1) FI111368B (el)
GR (1) GR3033985T3 (el)
HU (1) HU222274B1 (el)
IL (1) IL108050A (el)
MX (1) MX9400022A (el)
NO (1) NO313831B1 (el)
NZ (1) NZ258835A (el)
PL (1) PL177967B1 (el)
PT (1) PT604114E (el)
RU (1) RU2154065C2 (el)
SK (1) SK282409B6 (el)
WO (1) WO1994014815A1 (el)
ZA (1) ZA939560B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472964A (en) * 1992-12-22 1995-12-05 Merck Frosst Canada, Inc. Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
US5350760A (en) * 1993-08-04 1994-09-27 Merck Frosst Canada, Inc. Aza-5,5-fused hetrocyclic acids as leukotriene antagonists
TW448160B (en) * 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
US5491077A (en) * 1994-07-20 1996-02-13 Merck & Co., Inc. Microbial method
US5427933A (en) * 1994-07-20 1995-06-27 Merck & Co., Inc. Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy derivatives using mucor hiemalis IFO 5834
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5750539A (en) * 1995-06-07 1998-05-12 Merck Frosst Canada Heteroaryl diol acids as leukotriene antagonists
WO2003066582A1 (en) * 2002-02-06 2003-08-14 Delmar Chemicals Inc. Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
US7271268B1 (en) 2006-12-22 2007-09-18 Formosa Laboratories Inc. Process for preparation of [1-(mercaptomethyl)cyclopropyl]acetic acid and related derivatives
RU2449807C2 (ru) * 2009-11-16 2012-05-10 Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" Способ лечения эндотоксикоза при хроническом пиелонефрите

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957932A (en) * 1987-11-25 1990-09-18 Merck Frosst Canada, Inc. Benzoheterazoles
CA2053209C (en) * 1990-10-12 1998-12-08 Michel L. Belley Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
CA2053216C (en) * 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
EP0604114B1 (en) 2000-05-03
IL108050A (en) 1998-06-15
RU2154065C2 (ru) 2000-08-10
HUT71810A (en) 1996-02-28
AU5257993A (en) 1994-07-07
NO952495D0 (no) 1995-06-21
NO952495L (no) 1995-08-22
DE69328540T2 (de) 2001-01-04
CA2111372A1 (en) 1994-06-23
CZ290829B6 (cs) 2002-10-16
CZ165395A3 (en) 1996-01-17
CN1040213C (zh) 1998-10-14
NZ258835A (en) 1997-06-24
AU672837B2 (en) 1996-10-17
FI953104A0 (fi) 1995-06-21
CA2111372C (en) 2007-01-16
PT604114E (pt) 2000-09-29
ATE192448T1 (de) 2000-05-15
EP0604114A1 (en) 1994-06-29
HU9501842D0 (en) 1995-08-28
ES2145765T3 (es) 2000-07-16
WO1994014815A1 (en) 1994-07-07
SK82295A3 (en) 1995-12-06
KR950704325A (ko) 1995-11-17
HU222274B1 (hu) 2003-05-28
PL177967B1 (pl) 2000-02-29
ZA939560B (en) 1994-08-11
CN1094051A (zh) 1994-10-26
PL309408A1 (en) 1995-10-02
DE69328540D1 (de) 2000-06-08
FI953104A (fi) 1995-06-21
IL108050A0 (en) 1994-04-12
RU95113598A (ru) 1997-06-10
MX9400022A (es) 1995-01-31
SK282409B6 (sk) 2002-01-07
FI111368B (fi) 2003-07-15
KR100310552B1 (ko) 2001-12-17
NO313831B1 (no) 2002-12-09
DK0604114T3 (da) 2000-08-07

Similar Documents

Publication Publication Date Title
HRP930751B1 (en) Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
ZA932533B (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
ZA921232B (en) Quinoline-containing ketoacids as leukotriene antagonists
ZA939560B (en) Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists
EP0480708A3 (en) Hydroxyalkylquinoline ether acids as leukotriene antagonists
MY107767A (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees